Bio-Techne Corporation is a publicly traded company, listed on the Nasdaq stock exchange under the ticker symbol TECH. As a major player in the biotechnology and life sciences tools industry, it is owned by a diverse base of institutional and individual shareholders. Its status as a public entity means it must adhere to rigorous financial reporting standards, file quarterly and annual reports with the Securities and Exchange Commission, and maintain transparent governance practices overseen by a Board of Directors. Investors can buy and sell shares of Bio-Techne on the public markets during active trading hours, and the company’s corporate strategy and fiscal performance are subjected to regular scrutiny by equity analysts and the broader investment community. This structure allows the company to raise significant capital from the public markets to fuel its research, development, and strategic acquisition efforts across the global life sciences sector.